Pibrentasvir is an oral antiviral medication and NS5A inhibitor used in the treatment of chronic hepatitis C virus infection across genotypes 1 through 6. This category provides essential materials for… Read more

![Chemical structure of (2S,2'S)-2,2'-[[(2R,5R)-1-[3,5-Difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phenyl]-2,5-pyrrolidinediyl]bis(6-fluoro-1H-benzimidazole-5,2-diyl)]bis-1-pyrrolidinecarboxylic acid 1,1'-bis(1,1-dimethylethyl) ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1890114-11-0-2S2S-22-2R5R-1-35-Difluoro-4-4-4-fluorophenyl-1-piperidinylphenyl-25-pyrrolidinediylbis6-fluoro-1H-benzimidazole-52-diylbis-1-pyrrolidine.png&w=3840&q=75)
![Chemical structure of 3,5-Difluoro-4-[4-(4-fluorophenyl)piperidin-1-yl]aniline](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1332356-31-6-35-Difluoro-4-4-4-fluorophenylpiperidin-1-ylaniline.png&w=3840&q=75)
![Chemical structure of 5,5'-[(2R,5R)-1-[3,5-Difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phenyl]-2,5-pyrrolidinediyl]bis[6-fluoro-2-(2S)-2-pyrrolidinyl-1H-benzimidazole]](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1332357-14-8-55-2R5R-1-35-Difluoro-4-4-4-fluorophenyl-1-piperidinylphenyl-25-pyrrolidinediylbis6-fluoro-2-2S-2-pyrrolidinyl-1H-benzimidazole.png&w=3840&q=75)
![Chemical structure of Methyl ((2S,3R)-1-((S)-2-(6-((2R,5R)-1-(3,5-difluoro-4-(4-(4-fluorophenyl)piperidin-1-yl)phenyl)-5-(5-fluoro-2-((R)-1-(N-(methoxycarbonyl)-O-methyl-L-threonyl)pyrrolidin-2-yl)-1H-benzo[d]imidazol-6-yl)pyrrolidin-2-yl)-5-fluoro-1H-benzo[d]imidazol-2-yl)pyrrolidin-1-yl)-3-methoxy-1-oxobutan-2-yl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2412432-58-5-Methyl-2S3R-1-S-2-6-2R5R-1-35-difluoro-4-4-4-fluorophenylpiperidin-1-ylphenyl-5-5-fluoro-2-R-1-N-methoxycarbonyl-O-methyl-L-threonylpyrro.png&w=3840&q=75)









Pibrentasvir is an oral antiviral medication and NS5A inhibitor used in the treatment of chronic hepatitis C virus infection across genotypes 1 through 6. This category provides essential materials for pharmaceutical research and quality control, including high-quality reference standards of the Pibrentasvir active pharmaceutical ingredient. Laboratories rely on these specific compounds for comprehensive impurity profiling, method development, and regulatory compliance testing. Our collection encompasses a range of identified impurities and metabolites, allowing for precise identification and quantification of potential degradation products or synthesis-related byproducts. Additionally, stable isotope labelled versions of Pibrentasvir are available, which serve as critical internal standards for accurate analysis in bioanalytical studies and complex matrix evaluations, ensuring consistency and reliability throughout the pharmaceutical manufacturing and validation process.